<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32056106</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-4919</ISSN><JournalIssue CitedMedium="Internet"><Volume>466</Volume><Issue>1-2</Issue><PubDate><Year>2020</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Molecular and cellular biochemistry</Title><ISOAbbreviation>Mol Cell Biochem</ISOAbbreviation></Journal><ArticleTitle>Nucleation and kinetics of SOD1 aggregation in human cells for ALS1.</ArticleTitle><Pagination><StartPage>117</StartPage><EndPage>128</EndPage><MedlinePgn>117-128</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11010-020-03693-y</ELocationID><Abstract><AbstractText>Aberrant structural formations of Cu/Zn superoxide dismutase enzyme (SOD1) are the probable mechanism by which circumscribed mutations in the SOD1 gene cause familial amyotrophic lateral sclerosis (ALS1). SOD1 forms aberrant structures which can proceed by nucleation to insoluble aggregates. Here, the SOD1 aggregation reaction was investigated predominantly by time-course studies on ALS1 variants G85R, G37R, D101G, and D101N in human embryonic kidney cells (HEK293FT), with analysis by detergent ultracentrifugation extractions and high-resolution PAGE methodologies. Nucleation was found to be pseudo-zeroth order and dependent on time and concentration at constant 37.0&#xa0;&#xb0;C and pH 7.4. The predominant subsets of the total SOD1 expression set which comprised the nucleation phase were both soluble and insoluble inactive monomers, trimers, and hexamers with reduced intra-disulfide bonds. Superoxide exposure via paraquat initiated the formation of SOD1 trimers in untransfected SH-SY5Y cells and increased the aggregation propensity of G85R in HEK293FT. These data show the kinetic formation of aberrant SOD1 subsets implicated in ALS1 and indicate that superoxide substrate may initiate its radical polymerization. In an instance of the utility of methodological reductionism in molecular theory: though many ALS1 variants retain their global enzymatic activity, the SOD1 subsets most implicated in causing ALS1 do not retain their specific activity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Workman</LastName><ForeName>Aron</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6975-9213</Identifier><AffiliationInfo><Affiliation>AXOXY Laboratories, Weston, Florida, 33326, USA. aworkman@ufl.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McKnight Brain Institute, University of Florida, Gainesville, Florida, 32610, USA. aworkman@ufl.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mol Cell Biochem</MedlineTA><NlmUniqueID>0364456</NlmUniqueID><ISSNLinking>0300-8177</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020125" MajorTopicYN="Y">Mutation, Missense</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D041681" MajorTopicYN="N">NIH 3T3 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066263" MajorTopicYN="N">Protein Aggregation, Pathological</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Familial amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">High-resolution colorless native PAGE (hrcN-PAGE)</Keyword><Keyword MajorTopicYN="N">Polyacrylamide gel electrophoresis (PAGE)</Keyword><Keyword MajorTopicYN="N">Superoxide dismutase 1 (SOD1)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32056106</ArticleId><ArticleId IdType="doi">10.1007/s11010-020-03693-y</ArticleId><ArticleId IdType="pii">10.1007/s11010-020-03693-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pardo CA, Xu Z, Borchelt DR, Price DL, Sisodia SS, Cleveland DW (1995) Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc Natl Acad Sci USA 92:954&#x2013;958</Citation><ArticleIdList><ArticleId IdType="pubmed">7862672</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupeyrat F, Vidaud C, Lorphelin A, Berthomieu C (2004) Long distance charge redistribution upon Cu, Zn-superoxide dismutase reduction: significance for dismutase function. J Biol Chem 279:48091&#x2013;48101</Citation><ArticleIdList><ArticleId IdType="pubmed">15328354</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotilio G, Bray RC, Fielden EM (1972) A pulse radiolysis study of superoxide dismutase. Biochim Biophys Acta 268:605&#x2013;609</Citation><ArticleIdList><ArticleId IdType="pubmed">5026315</ArticleId></ArticleIdList></Reference><Reference><Citation>Forman HJ, Fridovich I (1973) Superoxide dismutase: a comparison of rate constants. Arch Biochem Biophys 158:396&#x2013;400</Citation><ArticleIdList><ArticleId IdType="pubmed">4354035</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddi AR, Culotta VC (2013) SOD1 integrates signals from oxygen and glucose to repress respiration. Cell 152:224&#x2013;235</Citation><ArticleIdList><ArticleId IdType="pubmed">23332757</ArticleId><ArticleId IdType="pmc">3552299</ArticleId></ArticleIdList></Reference><Reference><Citation>Liochev SI, Fridovich I (2000) Copper- and zinc-containing superoxide dismutase can act as a superoxide reductase and a superoxide oxidase. J Biol Chem 275:38482&#x2013;38485</Citation><ArticleIdList><ArticleId IdType="pubmed">11005823</ArticleId></ArticleIdList></Reference><Reference><Citation>Workman AS (2017) Real-time TD-DFT study on the dioxygen/superoxide radical charge transfer reaction. Comput Theor Chem 1117:207&#x2013;214</Citation></Reference><Reference><Citation>Nedd S, Redler RL, Proctor EA, Dokholyan NV, Alexandrova AN (2014) Cu, Zn-superoxide dismutase without Zn is folded but catalytically inactive. J Mol Biol 426:4112&#x2013;4124</Citation><ArticleIdList><ArticleId IdType="pubmed">25083917</ArticleId><ArticleId IdType="pmc">4258539</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L, Bertini I, Cantini F, Kozyreva T, Massagni C, Palumaa P, Rubino JT, Zovo K (2012) Human superoxide dismutase 1 (hSOD1) maturation through interaction with human copper chaperone for SOD1 (hCCS). Proc Natl Acad Sci USA 109:13555&#x2013;13560</Citation><ArticleIdList><ArticleId IdType="pubmed">22869735</ArticleId></ArticleIdList></Reference><Reference><Citation>Girotto S, Cendron L, Bisaglia M, Tessari I, Mammi S, Zanotti G, Bubacco L (2014) DJ-1 is a copper chaperone acting on SOD1 activation. J Biol Chem 289:10887&#x2013;10899</Citation><ArticleIdList><ArticleId IdType="pubmed">24567322</ArticleId><ArticleId IdType="pmc">4036200</ArticleId></ArticleIdList></Reference><Reference><Citation>Culotta VC, Klomp LW, Strain J, Casareno RLB, Krems B, Gitlin JD (1997) The copper chaperone for superoxide dismutase. J Biol Chem 272:23469&#x2013;23472</Citation><ArticleIdList><ArticleId IdType="pubmed">9295278</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L, Cantini F, Kozyreva T, Rubino JT (2013) Mechanistic aspects of hSOD1 maturation from the solution structure of CuI-Loaded hCCS domain 1 and analysis of disulfide-free hSOD1 mutants. ChemBioChem 14:1839&#x2013;1844</Citation><ArticleIdList><ArticleId IdType="pubmed">23625804</ArticleId></ArticleIdList></Reference><Reference><Citation>Leitch JM, Jensen LT, Bouldin SD, Outten CE, Hart PJ, Culotta VC (2009) Activation of Cu, Zn-superoxide dismutase in the absence of oxygen and the copper chaperone CCS. J Biol Chem 284:21863&#x2013;21871</Citation><ArticleIdList><ArticleId IdType="pubmed">19542232</ArticleId><ArticleId IdType="pmc">2756195</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown NM, Torres AS, Doan PE, O'Halloran TV (2004) Oxygen and the copper chaperone CCS regulate posttranslational activation of Cu, Zn superoxide dismutase. Proc Natl Acad Sci USA 101:5518&#x2013;5523</Citation><ArticleIdList><ArticleId IdType="pubmed">15064408</ArticleId></ArticleIdList></Reference><Reference><Citation>Seetharaman SV, Prudencio M, Karch C, Holloway SP, Borchelt DR, Hart PJ (2009) Immature copper&#x2013;zinc superoxide dismutase and familial amyotrophic lateral sclerosis. Exp Biol Med 234:1140&#x2013;1154</Citation></Reference><Reference><Citation>H&#xf6;rnberg A, Logan DT, Marklund SL, Oliveberg M (2007) The coupling between disulphide status, metallation and dimer interface strength in Cu/Zn superoxide dismutase. J Mol Biol 365:333&#x2013;342</Citation><ArticleIdList><ArticleId IdType="pubmed">17070542</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y, Torres AS, O'Halloran TV (2004) Oxygen-induced maturation of SOD1: a key role for disulfide formation by the copper chaperone CCS. EMBO J 23:2872&#x2013;2881</Citation><ArticleIdList><ArticleId IdType="pubmed">15215895</ArticleId><ArticleId IdType="pmc">1150991</ArticleId></ArticleIdList></Reference><Reference><Citation>Saccon RA, Bunton-Stasyshyn RK, Fisher EM, Fratta P (2013) Is SOD1 loss of function involved in amyotrophic lateral sclerosis? Brain 136:2342&#x2013;2358</Citation><ArticleIdList><ArticleId IdType="pubmed">23687121</ArticleId><ArticleId IdType="pmc">3722346</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunton-Stasyshyn RK, Saccon RA, Fratta P, Fisher EM (2015) SOD1 function and its implications for amyotrophic lateral sclerosis pathology: new and renascent themes. Neuroscientist 21:519&#x2013;529</Citation><ArticleIdList><ArticleId IdType="pubmed">25492944</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Rouleau GA, Ravits J, Cashman NR (2017) Clinical spectrum of amyotrophic lateral sclerosis (ALS). Cold Spring Harb Perspect Med</Citation></Reference><Reference><Citation>Black HA, Leighton DJ, Cleary EM, Rose E, Stephenson L, Colville S, Ross D, Warner J, Porteous M, Gorrie GH, Swingler R, Goldstein D, Harms MB, Connick P, Pal S, Aitman TJ, Chandran S (2016) Genetic epidemiology of motor neuron disease-associated variants in the Scottish population. Neurobiol Aging 51:178</Citation><ArticleIdList><ArticleId IdType="pubmed">28089114</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J, Burgunder J (2014) Recent progress in the genetics of motor neuron disease. Eur J Med Genet 57:103&#x2013;112</Citation><ArticleIdList><ArticleId IdType="pubmed">24503148</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel O, Powell JF, Andersen PM, Al-Chalabi A (2012) ALSoD: a user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics. Hum Mutat 33:1345&#x2013;1351</Citation><ArticleIdList><ArticleId IdType="pubmed">22753137</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng H, Rahmani Z, Krizus A, McKenna-Yasek D, Cayabyab A, Gaston SM, Berger R, Tanzi RE, Halperin JJ, Herzfeldt B, Van dB, Hung W, Bird T, Deng G, Mulder DW, Smyth C, Laing NG, Soriano E, Pericak-Vance M, Haines J, Rouleau GA, Gusella JS, Horvitz HR, Brown RH, (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362(6415):59&#x2013;62</Citation><ArticleIdList><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Xu G, Slunt HH, Gonzales V, Coonfield M, Fromholt D, Copeland NG, Jenkins NA, Borchelt DR (2005) Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA. Neurobiol Dis 20:943&#x2013;952</Citation><ArticleIdList><ArticleId IdType="pubmed">16046140</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM (2006) Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Curr Neurol Neurosci Rep 6:37&#x2013;46</Citation><ArticleIdList><ArticleId IdType="pubmed">16469270</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchelt DR, Lee MK, Slunt HS, Guarnieri M, Xu ZS, Wong PC, Brown RH Jr, Price DL, Sisodia SS, Cleveland DW (1994) Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci USA 91:8292&#x2013;8296</Citation><ArticleIdList><ArticleId IdType="pubmed">8058797</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Hart PJ, Borchelt DR, Andersen PM (2009) Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease. Hum Mol Genet 18:3217&#x2013;3226</Citation><ArticleIdList><ArticleId IdType="pubmed">19483195</ArticleId><ArticleId IdType="pmc">2722984</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers J, Lelie H, Workman A, Prudencio M, Brown H, Fromholt S, Valentine J, Whitelegge J, Borchelt D (2013) Distinctive features of the D101N and D101G variants of superoxide dismutase 1; two mutations that produce rapidly progressing motor neuron disease. J Neurochem 128:305&#x2013;314</Citation><ArticleIdList><ArticleId IdType="pubmed">24032979</ArticleId><ArticleId IdType="pmc">3971632</ArticleId></ArticleIdList></Reference><Reference><Citation>Bystrom R, Andersen PM, Grobner G, Oliveberg M (2010) SOD1 mutations targeting surface hydrogen bonds promote amyotrophic lateral sclerosis without reducing apo-state stability. J Biol Chem 285:19544&#x2013;19552</Citation><ArticleIdList><ArticleId IdType="pubmed">20189984</ArticleId><ArticleId IdType="pmc">2885233</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn L, Becher M, Lee M, Anderson K, Jenkins N, Copeland N, Sisodia S, Rothstein J, Borchelt D, Price D (1997) ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18:327&#x2013;338</Citation><ArticleIdList><ArticleId IdType="pubmed">9052802</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Caruano-Yzermans A, Rodriguez A, Scheurmann JP, Slunt HH, Cao X, Gitlin J, Hart PJ, Borchelt DR (2007) Disease-associated mutations at copper ligand histidine residues of superoxide dismutase 1 diminish the binding of copper and compromise dimer stability. J Biol Chem 282:345&#x2013;352</Citation><ArticleIdList><ArticleId IdType="pubmed">17092942</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler DD, Schuermann JP, Cao X, Holloway SP, Borchelt DR, Carroll MC, Proescher JB, Culotta VC, Hart PJ (2009) Structural and biophysical properties of the pathogenic SOD1 variant H46R/H48Q. Biochemistry 48:3436&#x2013;3447</Citation><ArticleIdList><ArticleId IdType="pubmed">19227972</ArticleId><ArticleId IdType="pmc">2757159</ArticleId></ArticleIdList></Reference><Reference><Citation>Elam JS, Taylor AB, Strange R, Antonyuk S, Doucette PA, Rodriguez JA, Hasnain SS, Hayward LJ, Valentine JS, Yeates TO (2003) Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS. Nat Struct Mol Biol 10:461&#x2013;467</Citation></Reference><Reference><Citation>Ray SS, Nowak RJ, Strokovich K, Brown RH, Walz T, Lansbury PT (2004) An intersubunit disulfide bond prevents in vitro aggregation of a superoxide dismutase-1 mutant linked to familial amytrophic lateral sclerosis. Biochemistry 43:4899&#x2013;4905</Citation><ArticleIdList><ArticleId IdType="pubmed">15109247</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakhit R, Crow JP, Lepock JR, Kondejewski LH, Cashman NR, Chakrabartty A (2004) Monomeric Cu, Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis. J Biol Chem 279:15499&#x2013;15504</Citation><ArticleIdList><ArticleId IdType="pubmed">14734542</ArticleId></ArticleIdList></Reference><Reference><Citation>Svensson AE, Bilsel O, Kayatekin C, Adefusika JA, Zitzewitz JA, Matthews CR (2010) Metal-free ALS variants of dimeric human Cu, Zn-superoxide dismutase have enhanced populations of monomeric species. PLoS ONE 5:e10064</Citation><ArticleIdList><ArticleId IdType="pubmed">20404910</ArticleId><ArticleId IdType="pmc">2852398</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L, Bertini I, Durazo A, Girotto S, Gralla EB, Martinelli M, Valentine JS, Vieru M, Whitelegge JP (2007) Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: a possible general mechanism for familial ALS. Proc Natl Acad Sci USA 104:11263&#x2013;11267</Citation><ArticleIdList><ArticleId IdType="pubmed">17592131</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayatekin C, Zitzewitz JA, Matthews CR (2010) Disulfide-reduced ALS variants of Cu, Zn superoxide dismutase exhibit increased populations of unfolded species. J Mol Biol 398:320&#x2013;331</Citation><ArticleIdList><ArticleId IdType="pubmed">20184893</ArticleId><ArticleId IdType="pmc">3075925</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdolvahabi A, Shi Y, Chuprin A, Rasouli S, Shaw BF (2016) Stochastic formation of fibrillar and amorphous superoxide dismutase oligomers linked to amyotrophic lateral sclerosis. ACS Chem Neurosci 7:799&#x2013;810</Citation><ArticleIdList><ArticleId IdType="pubmed">26979728</ArticleId></ArticleIdList></Reference><Reference><Citation>Karch CM, Prudencio M, Winkler DD, Hart PJ, Borchelt DR (2009) Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS. Proc Natl Acad Sci USA 106:7774&#x2013;7779</Citation><ArticleIdList><ArticleId IdType="pubmed">19416874</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw BF, Lelie HL, Durazo A, Nersissian AM, Xu G, Chan PK, Gralla EB, Tiwari A, Hayward LJ, Borchelt DR, Valentine JS, Whitelegge JP (2008) Detergent-insoluble aggregates associated with amyotrophic lateral sclerosis in transgenic mice contain primarily full-length, unmodified superoxide dismutase-1. J Biol Chem 283:8340&#x2013;8350</Citation><ArticleIdList><ArticleId IdType="pubmed">18192269</ArticleId><ArticleId IdType="pmc">2276386</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Xu G, Borchelt DR (2002) High molecular weight complexes of mutant superoxide dismutase 1: age-dependent and tissue-specific accumulation. Neurobiol Dis 9:139&#x2013;148</Citation><ArticleIdList><ArticleId IdType="pubmed">11895367</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Farr GW, Zeiss CJ, Rodriguez-Gil DJ, Wilson JH, Furtak K, Rutkowski DT, Kaufman RJ, Ruse CI, Yates JR, Perrin S, Feany MB, Horwich AL (2009) Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS. Proc Natl Acad Sci USA 106(5):1392&#x2013;1397</Citation><ArticleIdList><ArticleId IdType="pubmed">19171884</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Xu G, Gonzales V, Coonfield M, Fromholt D, Copeland NG, Jenkins NA, Borchelt DR (2002) Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site. Neurobiol Dis 10:128&#x2013;138</Citation><ArticleIdList><ArticleId IdType="pubmed">12127151</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratovitski T, Corson LB, Strain J, Wong P, Cleveland DW, Culotta VC, Borchelt DR (1999) Variation in the biochemical/biophysical properties of mutant superoxide dismutase 1 enzymes and the rate of disease progression in familial amyotrophic lateral sclerosis kindreds. Hum Mol Genet 8:1451&#x2013;1460</Citation><ArticleIdList><ArticleId IdType="pubmed">10400992</ArticleId></ArticleIdList></Reference><Reference><Citation>Synofzik M, Ronchi D, Keskin I, Basak AN, Wilhelm C, Gobbi C, Birve A, Biskup S, Zecca C, Fernandez-Santiago R, Kaugesaar T, Schols L, Marklund SL, Andersen PM (2012) Mutant superoxide dismutase-1 indistinguishable from wild-type causes ALS. Hum Mol Genet 21:3568&#x2013;3574</Citation><ArticleIdList><ArticleId IdType="pubmed">22595972</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Johnson JL, Agar NY, Agar JN (2008) Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival. PLoS Biol 6:e170</Citation><ArticleIdList><ArticleId IdType="pubmed">18666828</ArticleId><ArticleId IdType="pmc">2486295</ArticleId></ArticleIdList></Reference><Reference><Citation>Parge HE, Hallewell RA, Tainer JA (1992) Atomic structures of wild-type and thermostable mutant recombinant human Cu, Zn superoxide dismutase. Proc Natl Acad Sci USA 89:6109&#x2013;6113</Citation><ArticleIdList><ArticleId IdType="pubmed">1463506</ArticleId></ArticleIdList></Reference><Reference><Citation>Getzoff ED, Cabelli DE, Fisher CL, Parge HE, Viezzoli MS, Banci L, Hallewell RA (1992) Faster superoxide dismutase mutants designed by enhancing electrostatic guidance. Nature 358:347&#x2013;351</Citation><ArticleIdList><ArticleId IdType="pubmed">1353610</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleveland DW, Liu J (2000) Oxidation versus aggregation-how do SOD1 mutants cause ALS? Nat Med 6:1320&#x2013;1321</Citation><ArticleIdList><ArticleId IdType="pubmed">11100110</ArticleId></ArticleIdList></Reference><Reference><Citation>Salo DC, Pacifici RE, Lin SW, Giulivi C, Davies KJ (1990) Superoxide dismutase undergoes proteolysis and fragmentation following oxidative modification and inactivation. J Biol Chem 265:11919&#x2013;11927</Citation><ArticleIdList><ArticleId IdType="pubmed">2195028</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocheme HM, Murphy MP (2008) Complex I is the major site of mitochondrial superoxide production by paraquat. J Biol Chem 283:1786&#x2013;1798</Citation><ArticleIdList><ArticleId IdType="pubmed">18039652</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner BJ, Lopes EC, Cheema SS (2004) Inducible superoxide dismutase 1 aggregation in transgenic amyotrophic lateral sclerosis mouse fibroblasts. J Cell Biochem 91:1074&#x2013;1084</Citation><ArticleIdList><ArticleId IdType="pubmed">15034941</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare SD, Caplow M, Dokholyan NV (2004) The rate and equilibrium constants for a multistep reaction sequence for the aggregation of superoxide dismutase in amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 101:15094&#x2013;15099</Citation><ArticleIdList><ArticleId IdType="pubmed">15475574</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S, Lee S, Choi I, Yang YI, Kang T, Yi J (2013) Real-time analysis and direct observations of different superoxide dismutase (SOD1) molecules bindings to aggregates in temporal evolution step. Colloids Surf B 101:266&#x2013;271</Citation></Reference><Reference><Citation>McAlary L, Aquilina JA, Yerbury JJ (2016) Susceptibility of mutant SOD1 to form a destabilized monomer predicts cellular aggregation and toxicity but not in vitro aggregation propensity. Front Neurosci 10:499</Citation><ArticleIdList><ArticleId IdType="pubmed">27867347</ArticleId><ArticleId IdType="pmc">5095133</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang L, Zetterstrom P, Brannstrom T, Marklund SL, Danielsson J, Oliveberg M (2015) SOD1 aggregation in ALS mice shows simplistic test tube behavior. Proc Natl Acad Sci USA 112:9878&#x2013;9883</Citation><ArticleIdList><ArticleId IdType="pubmed">26221023</ArticleId></ArticleIdList></Reference><Reference><Citation>Karch CM, Borchelt DR (2008) A limited role for disulfide cross-linking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosis. J Biol Chem 283:13528&#x2013;13537</Citation><ArticleIdList><ArticleId IdType="pubmed">18316367</ArticleId><ArticleId IdType="pmc">2376231</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Slunt H, Gonzales V, Fromholt D, Coonfield M, Copeland NG, Jenkins NA, Borchelt DR (2003) Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. Hum Mol Genet 12:2753&#x2013;2764</Citation><ArticleIdList><ArticleId IdType="pubmed">12966034</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima S, Nagata S (1990) pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res 18:5322</Citation><ArticleIdList><ArticleId IdType="pubmed">1698283</ArticleId><ArticleId IdType="pmc">332193</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Lelie H, Brown HH, Whitelegge JP, Valentine JS, Borchelt DR (2012) A novel variant of human superoxide dismutase 1 harboring amyotrophic lateral sclerosis-associated and experimental mutations in metal-binding residues and free cysteines lacks toxicity in vivo. J Neurochem 121:475&#x2013;485</Citation><ArticleIdList><ArticleId IdType="pubmed">22332887</ArticleId><ArticleId IdType="pmc">3705958</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson LJ (1908) Concerning the relationship between the strength of acids and their capacity to preserve neutrality. Am J Physiol 21:173&#x2013;179</Citation></Reference><Reference><Citation>Hasselbalch KA (1916) Die berechnung der wasserstoffzahl des blutes aus der freien und gebundenen Kohlens&#xe4;ure desselben, und die sauerstoffbindung des blutes als funktion der wasserstoffzahl. Springer, Berlin</Citation></Reference><Reference><Citation>Chauhan OP, Singh S (1992) Order of reaction for sigmoidal curves. Biochem Educ 20:230&#x2013;230</Citation></Reference><Reference><Citation>Akaike H (1978) On the likelihood of a time series model. Stat 27(3&#x2013;4):217&#x2013;235</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>